700 SAGINAW DR, REDWOOD CITY, CA
Material disclosure
Other Events
Earnings Release
Reports First Quarter 2026 Financial Results and Update on Corporate Progress
Annual Report to Security Holders
Revolution Medicines Issues $500 Million Convertible Senior Notes
Equity Offering - Revolution Medicines, Inc. Issues 10.56M Shares at $142
Q2
Q1
FY 2024
Q3
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Definitive Merger Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Prospectus filed pursuant to Rule 305(b)(2)
Free Writing Prospectus